Expressing support for designation of the month of April 2024 as "Parkinson's Awareness Month".
The resolution itself does not alter existing laws but serves to mobilize support for Parkinson’s awareness and related initiatives. By designating April as a month dedicated to raising awareness, the resolution aims to enhance public understanding of Parkinson's disease, encourage additional research funding, and promote community support services. It also recognizes the vital role of clinical trials in the advancement of knowledge and treatment options for those affected by the disease.
House Resolution 1136 expresses support for the designation of April 2024 as 'Parkinson’s Awareness Month'. This resolution highlights the significance of raising awareness about Parkinson’s disease, which currently affects over a million individuals in the United States. The resolution emphasizes the urgency of addressing the growing prevalence of this neurodegenerative disease, which is predicted to nearly double by the year 2037, impacting millions of lives and costing the healthcare system an estimated $80 billion annually.
While the resolution is primarily supportive in nature, it reflects broader discussions regarding the need for more robust healthcare policies for neurodegenerative diseases. Advocates argue that increased focus on Parkinson's disease can drive funding toward research and boost community resources for patients and caregivers. However, there may be varying opinions on the adequacy of current federal and state responses to public health issues surrounding such diseases, fostering dialogue on healthcare priorities amongst lawmakers.